GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (OTCPK:FMCQF) » Definitions » Beneish M-Score

FMCQF (Fresenius Medical Care AG) Beneish M-Score : -2.75 (As of Dec. 15, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Fresenius Medical Care AG Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.75 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Fresenius Medical Care AG's Beneish M-Score or its related term are showing as below:

FMCQF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.05   Med: -2.61   Max: -2.34
Current: -2.75

During the past 13 years, the highest Beneish M-Score of Fresenius Medical Care AG was -2.34. The lowest was -3.05. And the median was -2.61.


Fresenius Medical Care AG Beneish M-Score Historical Data

The historical data trend for Fresenius Medical Care AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Beneish M-Score Chart

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.72 -3.05 -2.49 -2.59 -2.77

Fresenius Medical Care AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.85 -2.77 -2.75 -2.53 -2.75

Competitive Comparison of Fresenius Medical Care AG's Beneish M-Score

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Beneish M-Score falls into.



Fresenius Medical Care AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Fresenius Medical Care AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9013+0.528 * 0.9827+0.404 * 1.2288+0.892 * 1.0078+0.115 * 0.5794
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0089+4.679 * -0.041658-0.327 * 0.9573
=-2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was $3,600 Mil.
Revenue was 5283.019 + 5130.248 + 5135.35 + 5439.059 = $20,988 Mil.
Gross Profit was 1271.92 + 1255.113 + 1275.708 + 1471.107 = $5,274 Mil.
Total Current Assets was $8,980 Mil.
Total Assets was $36,083 Mil.
Property, Plant and Equipment(Net PPE) was $3,842 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,845 Mil.
Selling, General, & Admin. Expense(SGA) was $3,434 Mil.
Total Current Liabilities was $6,536 Mil.
Long-Term Debt & Capital Lease Obligation was $10,609 Mil.
Net Income was 236.404 + 201.292 + 77.129 + 205.013 = $720 Mil.
Non Operating Income was 45.505 + 35.522 + -125.509 + -223.78 = $-268 Mil.
Cash Flow from Operations was 1093.23 + 475.78 + 138.378 + 783.862 = $2,491 Mil.
Total Receivables was $3,964 Mil.
Revenue was 5267.876 + 5227.519 + 5036.403 + 5293.222 = $20,825 Mil.
Gross Profit was 1311.633 + 1296.858 + 1230.193 + 1303.786 = $5,142 Mil.
Total Current Assets was $9,663 Mil.
Total Assets was $38,031 Mil.
Property, Plant and Equipment(Net PPE) was $8,416 Mil.
Depreciation, Depletion and Amortization(DDA) was $1,948 Mil.
Selling, General, & Admin. Expense(SGA) was $3,377 Mil.
Total Current Liabilities was $7,064 Mil.
Long-Term Debt & Capital Lease Obligation was $11,811 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3600.444 / 20987.676) / (3963.961 / 20825.02)
=0.17155 / 0.190346
=0.9013

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5142.47 / 20825.02) / (5273.848 / 20987.676)
=0.246937 / 0.251283
=0.9827

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (8980.022 + 3842.397) / 36083.241) / (1 - (9662.973 + 8415.658) / 38030.625)
=0.644643 / 0.52463
=1.2288

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=20987.676 / 20825.02
=1.0078

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1947.501 / (1947.501 + 8415.658)) / (1844.565 / (1844.565 + 3842.397))
=0.187925 / 0.32435
=0.5794

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3433.934 / 20987.676) / (3377.338 / 20825.02)
=0.163617 / 0.162177
=1.0089

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10608.515 + 6536.071) / 36083.241) / ((11811.204 + 7064.387) / 38030.625)
=0.47514 / 0.496326
=0.9573

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(719.838 - -268.262 - 2491.25) / 36083.241
=-0.041658

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Fresenius Medical Care AG has a M-score of -2.71 suggests that the company is unlikely to be a manipulator.


Fresenius Medical Care AG Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

Fresenius Medical Care AG Headlines

From GuruFocus